VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
FCR and bevacizumab treatment in patients with relapsed chronic lymphocytic leukemia.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
FCR and bevacizumab treatment in patients with relapsed chronic lymphocytic leukemia.
FCR and bevacizumab treatment in patients with relapsed chronic lymphocytic leukemia. Cancer. 2014 Nov 15; 120(22):3494-501.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal, Humanized
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Combined Chemotherapy Protocols
Bevacizumab
Cyclophosphamide
Disease-Free Survival
Female
Humans
Leukemia, Lymphocytic, Chronic, B-Cell
Male
Middle Aged
Proportional Hazards Models
Recurrence
Rituximab
Vidarabine
authors with profiles
HAGOP M KANTARJIAN
ZEEV ESTROV
ALESSANDRA FERRAJOLI
WILLIAM G WIERDA
JAN ANDREAS BURGER
HUN JU LEE